Motor Systems
Motor System Examination
Involuntary Movements
Five Major Types Of Hyperkinetic Movement Disorders
Tremors
Most Common Example: Parkinsons Disease
Botox: First Indication Was For Strabismus Followed By Movement Disorder
Botox initially used for Strabismus
Botox was then approved for Cervical Dystonias
Dr. Joseph Jankovic introduced Botox for Cervical Dystonias
Dr. Jankovic has published over 1,200 original articles and over 55 books, is included among “Highly Cited Researchers”, and has been ranked
#1 expert in the world in Movement Disorders and in Botulinum Toxins.
He has served as the principal investigator in hundreds of clinical trials and his research on drugs for parkinsonian disorders and hyperkinetic movement disorders, including botulinum toxin (Botox) and tetrabenazine has led to their approval by the United States Food and Drug Administration.
He has led clinical and research team that focuses on etiology, pathophysiology, and experimental therapeutics of Parkinson’s disease and related neurodegenerative and movement disorders such as tremors, dystonia, Tourette syndrome, Huntington disease, restless legs syndrome, tardive dyskinesia, and paroxysmal dyskinesias. Under the direction of Dr. Jankovic the PDCMDC has been recognized as "Center of Excellence" by the Parkinson’s Foundation, the Huntington Disease Society of America, the Tourette Association of America, and the Wilson Disease Association.
Past president of the International Parkinson and Movement Disorder Society and of the International Neurotoxin Association.
Joseph Jankovic introduced Tetrabenazine to the World
Tetrabenazine is the only drug indicated for Huntingtons Disease
Snapshot
No comments:
Post a Comment